background
new
biomark
presepsin
found
valu
shown
diagnosi
evalu
sepsi
articl
brief
overview
new
biomark
data
sourc
literatur
search
use
multipl
databas
perform
articl
especi
metaanalys
systemat
review
random
control
trial
compar
marker
presepsin
seem
better
sensit
specif
diagnosi
sepsi
presepsin
suitabl
earli
diagnosi
sepsi
also
assess
sever
prognosi
conclus
presepsin
higher
sensit
specifi
citi
diagnosi
sepsi
new
biomark
predictor
prognosi
sepsi
importantli
preseptin
seem
play
crucial
role
supplement
method
earli
diagnosi
sepsi
sinc
multicent
studi
relationship
presepsin
sepsi
studi
clinic
valu
presepsin
need
sepsi
potenti
fatal
wholebodi
infl
ammat
system
inflammatori
respons
syndrom
sir
caus
sever
infect
clinic
manifest
vari
rapid
progress
costli
diseas
sepsi
lower
patient
live
qualiti
also
increas
mortal
signifi
cantli
sepsi
caus
million
death
global
year
unit
state
sepsi
affect
approxim
per
peopl
sever
sepsi
contribut
death
year
sepsi
occur
hospit
patient
account
much
icu
case
consensu
treatment
sepsi
indic
earli
antiinfect
treatment
given
comprehens
treatment
howev
due
exist
noninfecti
sir
mani
critic
patient
differenti
sepsi
sir
earli
stage
becom
hot
topic
mani
year
mani
report
biolog
marker
procalcitonin
pct
interleukin
provasopressin
creactiv
protein
crp
myeloid
cell
express
trigger
studi
biomark
sepsi
concern
diagnosi
assess
antibiot
treatment
prognosi
attract
extens
attent
research
except
pct
howev
clinic
valu
biomark
still
uncertain
controversi
new
biomark
presepsin
found
valu
shown
diagnosi
evalu
sepsi
articl
give
brief
overview
new
biomark
receptor
lipopolysaccharidelipopolysaccharid
bind
protein
lpslbp
complex
help
thinositol
lipid
structur
carboxyl
terminu
molecul
anchor
cell
membran
transduct
endotoxin
signal
tolllik
seri
downstream
tyrosin
protein
kinas
mitogenactiv
protein
kinas
gradual
activ
includ
nuclear
transcript
factor
thu
world
j
emerg
med
vol
lead
releas
cytokin
tumor
necrosi
subsequ
activ
secondari
inflammatori
cascad
acquir
immun
stimul
mononuclear
macrophag
neutrophil
endotheli
cell
releas
cytokin
cell
adhes
molecul
could
trigger
intens
excess
system
infl
ammatori
respons
activ
coagul
fibrinolyt
system
result
sir
sepsi
shock
dissemin
intravascular
coagul
dic
multipl
organ
dysfunct
syndrom
mod
two
form
membranebound
solubl
former
high
affi
niti
lp
mainli
express
cell
surfac
monocytesmacrophag
distribut
littl
bit
cell
surfac
neutrophil
latter
seen
plasma
produc
falloff
cell
secret
two
kind
could
detect
plasma
healthi
peopl
microgram
level
play
import
role
mediat
immun
respons
lp
cell
endotheli
cell
epitheli
cell
cleav
cathepsin
proteas
plasma
ntermin
fragment
constitut
subtyp
name
presepsin
recent
receptor
lpslbp
complex
could
activ
seri
signal
transduct
pathway
infl
ammatori
cascad
lead
system
infl
ammatori
respons
clinic
studi
relationship
sepsi
show
level
increas
significantli
patient
sepsi
septic
shock
compar
healthi
peopl
chang
significantli
relat
sever
prognosi
diseas
specif
poor
level
significantli
increas
patient
coronari
heart
diseas
heart
failur
liver
cirrhosi
high
blood
glucos
presepsin
gener
bodi
respons
bacteri
infect
phagocytosi
bacteria
may
play
major
role
simpli
give
infl
ammatori
respons
although
clear
presepsin
produc
bodi
research
believ
presepsin
like
sepsi
diagnost
biomark
high
sensit
specif
studi
shown
encourag
result
better
sensit
specif
pct
crp
commonli
use
biomark
diagnosi
sepsi
assess
sever
infect
guid
use
antibiot
metaanalysi
found
sensit
specif
pct
crp
vari
diagnosi
sepsi
sensit
high
declin
gradual
time
infect
extend
find
question
abil
distinguish
sepsi
sir
compar
marker
presepsin
seem
better
sensit
specifi
citi
diagnosi
sepsi
studi
found
plasma
concentr
presepsin
signifi
cantli
higher
infect
patient
noninfect
patient
shozushima
et
al
found
concentr
presepsin
pgml
sir
group
pgml
local
infect
group
pgml
sepsi
group
pgml
sever
sepsi
group
blood
concentr
presepsin
among
group
increas
sequenti
spanuth
et
al
studi
concentr
presepsin
emerg
patient
admiss
found
signifi
cantli
higher
sepsi
patient
healthi
peopl
also
signifi
cantli
higher
sever
sepsi
patient
sepsi
patient
moreov
concentr
presepsin
posit
correl
apach
ii
score
sofa
score
roc
curv
use
evalu
valu
four
marker
diagnosi
sepsi
auc
presepsin
presepsin
prefer
pct
crp
pgml
presepsin
cutoff
valu
sensit
diagnosi
sepsi
specif
wherea
pgml
taken
cutoff
valu
sensit
diagnosi
sepsi
specif
posit
predict
valu
neg
predict
valu
sensit
presepsin
diagnosi
sepsi
pct
blood
cultur
result
suggest
presepsin
may
advantag
diagnosi
sepsi
blood
cultur
perform
hour
diagnos
sepsi
posit
rate
low
pct
increas
hour
infect
reach
plateau
slowli
hour
peak
one
day
infect
compar
pct
presepsin
increas
earlier
faster
patient
sepsi
hour
infect
clp
sepsi
model
peak
hour
declin
hour
could
detect
earli
stage
infect
use
elisa
method
rescu
principl
indic
sepsi
diagnos
earli
infect
foci
detect
within
hour
treat
earli
antibiot
treatment
given
within
hour
diagnosi
world
j
emerg
med
vol
zou
et
al
sepsi
clinic
sepsi
biomark
high
sensit
specif
requir
addit
rapid
detect
method
accord
principl
chemiluminesc
enzym
immunoassay
minut
taken
pathfast
analysi
detect
presepsin
accuraci
method
similar
elisa
moreov
detect
plasma
serum
heparin
heparin
whole
blood
edta
anticoagul
serum
use
detect
sampl
assess
sever
prognosi
presepsin
biomark
suitabl
earli
diagnosi
sepsi
also
assess
sever
prognosi
albio
trial
patient
sever
sepsi
septic
shock
subject
assess
concentr
presepsin
pct
median
concentr
presepsin
pgml
dead
patient
fi
rst
day
admiss
signifi
cantli
higher
pgml
surviv
patient
day
presepsin
level
surviv
patient
declin
significantli
pgml
dead
patient
pgml
moreov
level
presepsin
correl
sofa
score
mof
score
hemodynam
stabil
mortal
patient
high
level
presepsin
significantli
higher
patient
low
level
presepsin
presepsin
superior
pct
assess
prognosi
auc
anoth
studi
show
level
presepsin
signifi
cantli
differ
surviv
group
death
group
even
sepsi
group
sever
sepsi
group
septic
shock
group
presepsin
better
crp
pct
assess
risk
death
within
day
onset
sepsi
cutoff
valu
presepsin
pgml
cutoff
valu
pct
ngml
pct
group
surviv
patient
could
alloc
death
group
dead
patient
assign
surviv
patient
combin
med
presepsin
could
reclassifi
correct
group
indic
presepsin
might
better
abil
predict
risk
death
defici
preliminari
studi
shown
presepsin
highli
accur
specif
diagnosi
sepsi
fast
conveni
detect
sepsi
assess
sever
prognosi
sepsi
receptor
lp
compon
gramneg
bacteri
cell
wall
easi
imagin
whether
presepsin
predic
sepsi
caus
gramposit
cocci
infect
studi
shown
sensit
presepsin
pct
patient
gramposit
bacteri
infect
gramneg
bacteri
infect
sensit
presepsin
differ
significantli
patient
gramposit
gramneg
bacteri
infect
addit
level
presepsin
could
increas
patient
fungal
infect
patient
viru
infect
immedi
report
presepsin
level
patient
atyp
pathogen
infect
without
mycobacterium
tuberculosi
infect
recent
studi
found
patient
renal
failur
median
level
presepsin
patient
sepsi
sepsi
pgml
rang
pgml
rang
respect
differ
two
group
howev
median
level
presepsin
signifi
cantli
differ
patient
without
sepsi
sepsi
nonaki
patient
risk
patient
injur
patient
clear
diagnosi
presepsin
level
affect
kidney
function
summari
studi
show
presepsin
higher
sensit
specif
diagnosi
sepsi
new
biomark
predictor
prognosi
sepsi
importantli
preseptin
seem
play
crucial
role
supplement
method
earli
diagnosi
sepsi
sinc
multicent
studi
relationship
presepsin
sepsi
studi
clinic
valu
presepsin
need
fund
none
ethic
approv
need
confl
ict
interest
author
declar
confl
ict
interest
contributor
zou
q
propos
studi
analyz
data
wrote
first
draft
author
contribut
design
interpret
studi
draft
